Trofinetide Completed Phase 2 Trials for Injuries, Brain Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01366820Study of NNZ-2566 in Patients With Traumatic Brain Injury Under EFIC